Head and Neck Cancer

Written By Karen Dindial

The Challenge

A global biopharmaceutical company wanted to create a policy and advocacy launch strategy for a novel treatment in development for head and neck  squamous cell carcinomas (HNSCC) – a new indication for this team.

Our Solution

  • Analyzed government and payer policies, funding and resourcing priorities, gaps, and proposed legislation.

  • Mapped patient experience to understand unmet needs:

    • Insufficient curative treatments

    • Poor outcomes due to underdiagnosis and late diagnosis

    • Increased risk of depression and suicidality among stigmatized survivors

    • Disparities in access to care and socioeconomic status

  • Chartered the advocacy landscape recommending organizations and KOLs.

  • Identified shared interests and engagement opportunities aligned to strategic imperatives and launch timelines.

  • Reviewed competitor activities to identify program strengths and gaps.

  • Developed a strategic plan to guide policy and patient advocacy engagement activities.

  • Drafted an operational plan to support smooth execution.

Benefit to Client

  • Comprehensive HNSCC Policy and Advocacy Insights: Attained insights into the current and evolving HNSCC policy and advocacy landscape.

  • Influential Stakeholder Comprehension: Understanding of key stakeholders influencing the HNSCC space, unmet patient needs they are working to address, and partnership opportunities to leverage.

  • Strategic Engagement Blueprint: Developed a policy and advocacy engagement strategy supporting product launch needs.

  • Policy Monitoring and Stakeholder Engagement: Established a well-defined plan for monitoring pertinent policies in the HNSCC arena and engaging with relevant stakeholders.

Karen Dindial
Previous

Lung Cancer